GetTopicDetailResponse(id=23416231447, topicName=格林森評分, introduction=格林森評分, content=null, image=null, comments=4, allHits=1285, url=https://h5.medsci.cn/topic?id=62314, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=79490, tagList=[TagDto(tagId=79490, tagName=格林森評分)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1664264, encodeId=4a2e166426423, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森評分#</a>, objectTitle=Cancer：前列腺癌活檢格林森評分9到10患者的前列腺特異性抗原水平和前列腺癌特異性死亡風險 , objectType=article, longId=213155, objectId=80b4213155e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80b4213155e3, replyNumber=0, likeNumber=120, createdTime=2022-03-04, rootId=0, userName=ms5353107019656438, userId=2ecb25719968, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80b4213155e3, moduleTitle=Cancer：前列腺癌活檢格林森評分9到10患者的前列腺特異性抗原水平和前列腺癌特異性死亡風險 , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=80b4213155e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1664263, encodeId=ae3d16642636e, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森評分#</a>, objectTitle=Urol Int：在低風險前列腺癌患者中，中性粒細胞、血小板和嗜酸性粒細胞/淋巴細胞比例能夠預測格林森評分升級, objectType=article, longId=153897, objectId=d46915389ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d46915389ed7, replyNumber=0, likeNumber=86, createdTime=2019-06-24, rootId=0, userName=ms5353107019656438, userId=2ecb25719968, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d46915389ed7, moduleTitle=Urol Int：在低風險前列腺癌患者中，中性粒細胞、血小板和嗜酸性粒細胞/淋巴細胞比例能夠預測格林森評分升級, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d46915389ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1664261, encodeId=5a7f1664261ac, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森評分#</a>, objectTitle=Sci Rep：通過深度學習對前列腺癌組織芯片的自動化格林森評分研究, objectType=article, longId=147351, objectId=b2ed14e3514c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2ed14e3514c, replyNumber=0, likeNumber=81, createdTime=2019-08-04, rootId=0, userName=ms5353107019656438, userId=2ecb25719968, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2ed14e3514c, moduleTitle=Sci Rep：通過深度學習對前列腺癌組織芯片的自動化格林森評分研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b2ed14e3514c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1664262, encodeId=b4ae1664262e4, content=<a href='/topic/show?id=23416231447' target=_blank style='color:#2F92EE;'>#格林森評分#</a>, objectTitle=Sci Rep：不同格林森評分前列腺癌中類固醇激素受體和基質(zhì)細胞標記表達比較, objectType=article, longId=150803, objectId=69d4150803ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69d4150803ca, replyNumber=0, likeNumber=84, createdTime=2019-03-16, rootId=0, userName=ms5353107019656438, userId=2ecb25719968, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69d4150803ca, moduleTitle=Sci Rep：不同格林森評分前列腺癌中類固醇激素受體和基質(zhì)細胞標記表達比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=69d4150803ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
